82 FR 32704 - Proposed Data Collection Submitted for Public Comment and Recommendations
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention Federal Register Volume 82, Issue 135 (July 17, 2017)
Centers for Disease Control and Prevention
Federal Register Volume 82, Issue 135 (July 17, 2017)
| Page Range | 32704-32705 | |
| FR Document | 2017-14914 |
[Federal Register Volume 82, Number 135 (Monday, July 17, 2017)] [Notices] [Pages 32704-32705] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2017-14914] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [60Day-17-17AMP; Docket No. CDC-2017-0057] Proposed Data Collection Submitted for Public Comment and Recommendations AGENCY: Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice with comment period. ----------------------------------------------------------------------- SUMMARY: The Centers for Disease Control and Prevention (CDC), as part of its continuing efforts to reduce public burden and maximize the utility of government information, invites the general public and other Federal agencies to take this opportunity to comment on proposed and/or continuing information collections, as required by the Paperwork Reduction Act of 1995. This notice invites comment on a proposed information collection entitled ``Evaluation of the SAMHSA Naloxone Education and Distribution Program.'' CDC will use the information collected to evaluate the program ``Substance Abuse and Mental Health Services Agency (SAMHSA) Grants to Prevent Prescription Drug/Opioid Overdose-Related Deaths.'' The program was recently funded to improve access to treatment for opioid use disorders, reduce opioid related deaths, and strengthen drug misuse prevention efforts. DATES: Written comments must be received on or before September 15, 2017. ADDRESSES: You may submit comments, identified by Docket No. CDC-2017- 0057 by any of the following methods:Federal eRulemaking Portal: Regulations.gov. Follow the instructions for submitting comments. Mail: Leroy A. Richardson, Information Collection Review Office, Centers for Disease Control and Prevention, 1600 Clifton Road NE., MS-D74, Atlanta, Georgia 30329. Instructions: All submissions received must include the agency name and Docket Number. All relevant comments received will be posted without change to Regulations.gov, including any personal information provided. For access to the docket to read background documents or comments received, go to Regulations.gov. Please note: All public comment should be submitted through the Federal eRulemaking portal (Regulations.gov) or by U.S. mail to the address listed above. FOR FURTHER INFORMATION CONTACT: To request more information on the proposed project or to obtain a copy of the information collection plan and instruments, contact LeRoy A. Richardson, Information Collection Review Office, Centers for Disease Control and Prevention, 1600 Clifton Road NE., MS-D74, Atlanta, Georgia 30329; phone: 404-639-7570; Email: [email protected]. SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995 (PRA) (44 U.S.C. 3501-3520), Federal agencies must obtain approval from the Office of Management and Budget (OMB) for each collection of information they conduct or sponsor. In addition, the PRA also requires Federal agencies to provide a 60-day notice in the Federal Register concerning each proposed collection of information, including each new proposed collection, each proposed extension of existing collection of information, and each reinstatement of previously approved information collection before submitting the collection to OMB for approval. To comply with this requirement, we are publishing this notice of a proposed data collection as described below. Comments are invited on: (a) Whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information shall have practical utility; (b) the accuracy of the agency's estimate of the burden of the proposed collection of information; (c) ways to enhance the quality, utility, and clarity of the information to be collected; (d) ways to minimize the burden of the collection of information on respondents, including through the use of automated collection techniques or other forms of information technology; and (e) estimates of capital or start- up costs and costs of operation, maintenance, and purchase of services to provide information. Burden means the total time, effort, or financial resources expended by persons to generate, maintain, retain, disclose or provide information to or for a Federal agency. This includes the time needed to review instructions; to develop, acquire, install and utilize technology and systems for the purpose of collecting, validating and verifying information, processing and maintaining information, and disclosing and providing information; to train personnel and to be able to respond to a collection of information, to search data sources, to complete and review the collection of information; and to transmit or otherwise disclose the information. Proposed Project Evaluation of the SAMHSA Naloxone Education and Distribution Program--New--National Center for Injury Prevention and Control (NCIPC), Centers for Disease Control and Prevention (CDC). [[Page 32705]] Background and Brief Description Overdose deaths involving prescription opioids and heroin have reached epidemic levels in the U.S. and continue to rise. To address the prescription drug/opioid overdose crisis, the federal government has recently allocated funding to improve access to treatment for opioid use disorders, reduce opioid related deaths, and strengthen drug misuse prevention efforts. One program resulting from the federal government's efforts to address the opioid crisis is, the Substance Abuse and Mental Health Services Agency (SAMHSA) Grants to Prevent Prescription Drug/Opioid Overdose-Related Deaths (PDO/naloxone grant). This collection will be to evaluate the Substance Abuse and Mental Health Services Agency (SAMHSA) Grants to Prevent Prescription Drug/ Opioid Overdose-Related Deaths. This evaluation will seek to describe and understand the scope and impact of the program on overdose. To address the prescription drug/ opioid overdose crisis, the federal government has recently allocated funding to improve access to treatment for opioid use disorders, reduce opioid related deaths, and strengthen drug misuse prevention efforts. One program resulting from the federal government's efforts to address the opioid crisis is, the Substance Abuse and Mental Health Services Agency (SAMHSA) Grants to Prevent Prescription Drug/Opioid Overdose- Related Deaths (PDO/naloxone grant). Through this program, SAMHSA awarded funding to 12 states. The funding is aimed at reducing the number of prescription drug/opioid overdose-related deaths and adverse events among individuals 18 years of age and older through educating and training first responders and other key community sectors on the prevention of prescription drug/opioid overdose-related deaths, including the purchase and distribution of naloxone. SAMHSA is funding the grant and CDC is responsible for conducting the grantee evaluation. The intended use of the resulting data is to increase CDC and SAMHSA understanding of the scope and impact of the program on overdose fatalities and how program effectiveness may vary among different sub- populations and settings, and to increase knowledge of barriers and facilitators to program implementation. Key informant interviews and focus groups with participants in the activities enacted by the twelve state grant recipients will be methodology used. This will include state administrators of the grant and other PDO/Naloxone stakeholders including advisory council members, first responders, social service providers, laypersons including end users and their family and friend. All focus groups and interviews will be analyzed through qualitative content analysis, including utilization of a systematic coding scheme. Total burden in hours for this collection is 381. There are no costs to respondents other than their time. Estimated Annualized Burden Hours ---------------------------------------------------------------------------------------------------------------- Number of Average burden Type of respondents Form name Number of responses per per response Total burden respondents respondent (in hours) (in hours) ---------------------------------------------------------------------------------------------------------------- PDO/Naloxone Advisory Focus Group 140 1 1.5 210 Committee Members and Discussion Grantees. Guide. PDO/Naloxone Grantees......... Individual 36 1 1 36 Interview Discussion Guide for Grantees. PDO/Naloxone Stakeholders and Individual 84 1 1 84 Partners. Interview Discussion Guide for Partners. PDO/Naloxone Laypersons....... Individual 24 1 1 24 Interview Discussion Guide for Laypersons. All participants (PDO Naloxone Recruitment 284 1 5/60 24 grantees, advisory committee, contact script. stakeholders and partners, laypersons). PDO/Naloxone Grantees......... Key Informant 12 1 15/60 3 Selection Tool. --------------------------------------------------------------- Total..................... ................ .............. .............. .............. 381 ---------------------------------------------------------------------------------------------------------------- Leroy A. Richardson, Chief, Information Collection Review Office, Office of Scientific Integrity, Office of the Associate Director for Science, Office of the Director, Centers for Disease Control and Prevention. [FR Doc. 2017-14914 Filed 7-14-17; 8:45 am] BILLING CODE 4163-18-P
![32704 Federal Register / Vol. 82, No. 135 / Monday, July 17, 2017 / Notices
There are no costs to the responders
other than their time.
ESTIMATED ANNUALIZED BURDEN HOURS
Avgerage
Number of
Number of burden per
Type of respondents Form name responses per
respondents response
respondent (in hours)
Receptionist ............................................................................ Pre-call ................................... 300 1 5/60
Occupational health and safety specialists ............................. Survey .................................... 100 1 20/60
Industrial Production Managers .............................................. Survey .................................... 75 1 20/60
Natural Sciences Managers .................................................... Survey .................................... 75 1 20/60
Leroy A. Richardson, DATES: Written comments must be previously approved information
Chief, Information Collection Review Office, received on or before September 15, collection before submitting the
Office of Scientific Integrity, Office of the 2017. collection to OMB for approval. To
Associate Director for Science, Office of the comply with this requirement, we are
ADDRESSES: You may submit comments,
Director, Centers for Disease Control and publishing this notice of a proposed
Prevention. identified by Docket No. CDC–2017–
0057 by any of the following methods: data collection as described below.
[FR Doc. 2017–14912 Filed 7–14–17; 8:45 am]
• Federal eRulemaking Portal: Comments are invited on: (a) Whether
BILLING CODE 4163–18–P Regulations.gov. Follow the instructions the proposed collection of information
for submitting comments. is necessary for the proper performance
• Mail: Leroy A. Richardson,
DEPARTMENT OF HEALTH AND of the functions of the agency, including
Information Collection Review Office,
HUMAN SERVICES Centers for Disease Control and whether the information shall have
Prevention, 1600 Clifton Road NE., MS– practical utility; (b) the accuracy of the
Centers for Disease Control and D74, Atlanta, Georgia 30329. agency’s estimate of the burden of the
Prevention proposed collection of information; (c)
Instructions: All submissions received
must include the agency name and ways to enhance the quality, utility, and
[60Day–17–17AMP; Docket No. CDC–2017– Docket Number. All relevant comments clarity of the information to be
0057] received will be posted without change collected; (d) ways to minimize the
to Regulations.gov, including any burden of the collection of information
Proposed Data Collection Submitted personal information provided. For on respondents, including through the
for Public Comment and access to the docket to read background use of automated collection techniques
Recommendations documents or comments received, go to or other forms of information
Regulations.gov. technology; and (e) estimates of capital
AGENCY: Centers for Disease Control and Please note: All public comment or start-up costs and costs of operation,
Prevention (CDC), Department of Health should be submitted through the maintenance, and purchase of services
and Human Services (HHS). Federal eRulemaking portal to provide information. Burden means
ACTION: Notice with comment period. (Regulations.gov) or by U.S. mail to the the total time, effort, or financial
address listed above. resources expended by persons to
SUMMARY: The Centers for Disease FOR FURTHER INFORMATION CONTACT: To generate, maintain, retain, disclose or
Control and Prevention (CDC), as part of request more information on the provide information to or for a Federal
its continuing efforts to reduce public proposed project or to obtain a copy of agency. This includes the time needed
burden and maximize the utility of the information collection plan and to review instructions; to develop,
government information, invites the instruments, contact LeRoy A. acquire, install and utilize technology
general public and other Federal Richardson, Information Collection and systems for the purpose of
agencies to take this opportunity to Review Office, Centers for Disease collecting, validating and verifying
comment on proposed and/or Control and Prevention, 1600 Clifton information, processing and
continuing information collections, as Road NE., MS–D74, Atlanta, Georgia maintaining information, and disclosing
required by the Paperwork Reduction 30329; phone: 404–639–7570; Email:
and providing information; to train
Act of 1995. This notice invites omb@cdc.gov.
personnel and to be able to respond to
comment on a proposed information SUPPLEMENTARY INFORMATION: Under the
a collection of information, to search
collection entitled ‘‘Evaluation of the Paperwork Reduction Act of 1995 (PRA)
data sources, to complete and review
SAMHSA Naloxone Education and (44 U.S.C. 3501–3520), Federal agencies
the collection of information; and to
Distribution Program.’’ CDC will use the must obtain approval from the Office of
transmit or otherwise disclose the
information collected to evaluate the Management and Budget (OMB) for each
information.
asabaliauskas on DSKBBXCHB2PROD with NOTICES
program ‘‘Substance Abuse and Mental collection of information they conduct
Health Services Agency (SAMHSA) or sponsor. In addition, the PRA also Proposed Project
Grants to Prevent Prescription Drug/ requires Federal agencies to provide a
Opioid Overdose-Related Deaths.’’ The 60-day notice in the Federal Register Evaluation of the SAMHSA Naloxone
program was recently funded to concerning each proposed collection of Education and Distribution Program—
improve access to treatment for opioid information, including each new New—National Center for Injury
use disorders, reduce opioid related proposed collection, each proposed Prevention and Control (NCIPC),
deaths, and strengthen drug misuse extension of existing collection of Centers for Disease Control and
prevention efforts. information, and each reinstatement of Prevention (CDC).
VerDate Sep<11>2014 17:45 Jul 14, 2017 Jkt 241001 PO 00000 Frm 00029 Fmt 4703 Sfmt 4703 E:\FR\FM\17JYN1.SGM 17JYN1](https://thefederalregister.org/doc/82_FR_32839/page/1.svg)
![Federal Register / Vol. 82, No. 135 / Monday, July 17, 2017 / Notices 32705
Background and Brief Description crisis, the federal government has The intended use of the resulting data
Overdose deaths involving recently allocated funding to improve is to increase CDC and SAMHSA
prescription opioids and heroin have access to treatment for opioid use understanding of the scope and impact
reached epidemic levels in the U.S. and disorders, reduce opioid related deaths, of the program on overdose fatalities
continue to rise. To address the and strengthen drug misuse prevention and how program effectiveness may
prescription drug/opioid overdose efforts. One program resulting from the vary among different sub-populations
crisis, the federal government has federal government’s efforts to address and settings, and to increase knowledge
recently allocated funding to improve the opioid crisis is, the Substance Abuse of barriers and facilitators to program
access to treatment for opioid use and Mental Health Services Agency implementation. Key informant
disorders, reduce opioid related deaths, (SAMHSA) Grants to Prevent interviews and focus groups with
and strengthen drug misuse prevention Prescription Drug/Opioid Overdose- participants in the activities enacted by
efforts. One program resulting from the Related Deaths (PDO/naloxone grant). the twelve state grant recipients will be
federal government’s efforts to address Through this program, SAMHSA methodology used. This will include
the opioid crisis is, the Substance Abuse awarded funding to 12 states. The state administrators of the grant and
and Mental Health Services Agency funding is aimed at reducing the other PDO/Naloxone stakeholders
(SAMHSA) Grants to Prevent number of prescription drug/opioid including advisory council members,
Prescription Drug/Opioid Overdose- overdose-related deaths and adverse first responders, social service
Related Deaths (PDO/naloxone grant). events among individuals 18 years of
providers, laypersons including end
This collection will be to evaluate the age and older through educating and
users and their family and friend. All
Substance Abuse and Mental Health training first responders and other key
focus groups and interviews will be
Services Agency (SAMHSA) Grants to community sectors on the prevention of
prescription drug/opioid overdose- analyzed through qualitative content
Prevent Prescription Drug/Opioid
related deaths, including the purchase analysis, including utilization of a
Overdose-Related Deaths.
This evaluation will seek to describe and distribution of naloxone. SAMHSA systematic coding scheme.
and understand the scope and impact of is funding the grant and CDC is Total burden in hours for this
the program on overdose. To address the responsible for conducting the grantee collection is 381. There are no costs to
prescription drug/opioid overdose evaluation. respondents other than their time.
ESTIMATED ANNUALIZED BURDEN HOURS
Average
Number of
Number of burden per Total burden
Type of respondents Form name responses per
respondents response (in hours)
respondent (in hours)
PDO/Naloxone Advisory Committee Focus Group Discussion Guide ....... 140 1 1.5 210
Members and Grantees.
PDO/Naloxone Grantees .................. Individual Interview Discussion 36 1 1 36
Guide for Grantees.
PDO/Naloxone Stakeholders and Individual Interview Discussion 84 1 1 84
Partners. Guide for Partners.
PDO/Naloxone Laypersons .............. Individual Interview Discussion 24 1 1 24
Guide for Laypersons.
All participants (PDO Naloxone Recruitment contact script ............... 284 1 5/60 24
grantees, advisory committee,
stakeholders and partners,
laypersons).
PDO/Naloxone Grantees .................. Key Informant Selection Tool ........... 12 1 15/60 3
Total ........................................... ........................................................... ........................ ........................ ........................ 381
Leroy A. Richardson, DEPARTMENT OF HEALTH AND its continuing efforts to reduce public
Chief, Information Collection Review Office, HUMAN SERVICES burden and maximize the utility of
Office of Scientific Integrity, Office of the government information, invites the
Associate Director for Science, Office of the Centers for Disease Control and general public and other Federal
Director, Centers for Disease Control and Prevention agencies to take this opportunity to
Prevention. comment on proposed and/or
[60Day–17–1054; Docket No. CDC–2017–
[FR Doc. 2017–14914 Filed 7–14–17; 8:45 am] 0055] continuing information collections, as
BILLING CODE 4163–18–P required by the Paperwork Reduction
Proposed Data Collection Submitted Act of 1995. This notice invites
for Public Comment and comment on a proposed information
asabaliauskas on DSKBBXCHB2PROD with NOTICES
Recommendations collection entitled ‘‘Drug Overdose
AGENCY: Centers for Disease Control and Response Investigation (DORI) Data
Prevention (CDC), Department of Health Collections.’’ CDC will use the
and Human Services (HHS). information collected to respond to
ACTION: Notice with comment period. urgent requests from state and local
health authorities to provide
SUMMARY: The Centers for Disease epidemiological information that allows
Control and Prevention (CDC), as part of
VerDate Sep<11>2014 17:45 Jul 14, 2017 Jkt 241001 PO 00000 Frm 00030 Fmt 4703 Sfmt 4703 E:\FR\FM\17JYN1.SGM 17JYN1](https://thefederalregister.org/doc/82_FR_32839/page/2.svg)
Document Created: 2017-07-15 03:45:48
Document Modified: 2017-07-15 03:45:48
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Action | Notice with comment period. | |
| Dates | Written comments must be received on or before September 15, 2017. | |
| Contact | To request more information on the proposed project or to obtain a copy of the information collection plan and instruments, contact LeRoy A. Richardson, Information Collection Review Office, Centers for Disease Control and Prevention, 1600 Clifton Road NE., MS-D74, Atlanta, Georgia 30329; phone: 404-639-7570; Email: [email protected] | |
| FR Citation | 82 FR 32704 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR